ALDH1A1 and neoplasm: The positive rates of CD133, CD44v6, ALDH1 and LGR5 expression in the primary tumour samples were 59.2% (173/292), 72.9% (213/292), 45.9% (134/292) and 81.8% (239/292), respectively.